Matches in Nanopublications for { ?s ?p "[The human epidermal growth factor receptor-2 (HER2) is overexpressed and/or amplified in up to 25% of breast cancer patients, and this feature is associated with an aggressive phenotype, high recurrence rate and reduced survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[The human epidermal growth factor receptor-2 (HER2) is overexpressed and/or amplified in up to 25% of breast cancer patients, and this feature is associated with an aggressive phenotype, high recurrence rate and reduced survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP692081.RABscjeiDmVM_CnZKC7sDy8DNYaRCTmTnWjPI14gqu5a4130_assertion description "[The human epidermal growth factor receptor-2 (HER2) is overexpressed and/or amplified in up to 25% of breast cancer patients, and this feature is associated with an aggressive phenotype, high recurrence rate and reduced survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692081.RABscjeiDmVM_CnZKC7sDy8DNYaRCTmTnWjPI14gqu5a4130_provenance.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion description "[The human epidermal growth factor receptor-2 (HER2) is overexpressed and/or amplified in up to 25% of breast cancer patients, and this feature is associated with an aggressive phenotype, high recurrence rate and reduced survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_provenance.